Effective implementation of pharmacogenetic guidelines, clinical utility of genotyping vs phenotyping at the enzyme level, the cost-effectiveness of such approaches, and the innovative application of a pre-emptive pharmacogenomics panel are subjects of study within the APH-Personalized Medicine program.
With these approaches there are many values at strike. Time for a debate with experts.
Mark your calendar. More detailed info will follow soon.